Ardent Health (NYSE:ARDT – Free Report) had its price target upped by Truist Financial from $13.00 to $22.00 in a research note issued to investors on Tuesday,Benzinga reports. Truist Financial currently has a buy rating on the stock.
A number of other research firms also recently weighed in on ARDT. Wall Street Zen raised shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Weiss Ratings upgraded shares of Ardent Health from a “sell (d+)” rating to a “hold (c)” rating in a research note on Monday, November 9th. Guggenheim lifted their price target on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Royal Bank Of Canada lifted their price target on shares of Ardent Health from $13.00 to $18.00 and gave the company an “outperform” rating in a research report on Friday, November 6th. Finally, Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Monday, September 7th. Seven equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $15.68.
View Our Latest Report on ARDT
Ardent Health Price Performance
Shares of ARDT stock opened at $14.44 on Tuesday. The stock has a market cap of $2.03 billion, a price-to-earnings ratio of 13.98, a PEG ratio of 2.62 and a beta of 0.58. The business’s fifty day moving average is $12.56 and its 200 day moving average is $10.49. Ardent Health has a twelve month low of $7.71 and a twelve month high of $18.57. The company has a quick ratio of 2.03, a current ratio of 2.13 and a debt-to-equity ratio of 0.60.
Ardent Health (NYSE:ARDT – Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08. The business had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.60 billion. Ardent Health had a return on equity of 8.41% and a net margin of 2.27%. Research analysts expect that Ardent Health will post 1.04 EPS for the current fiscal year.
Hedge Funds Weigh In On Ardent Health
A number of hedge funds have recently added to or reduced their stakes in ARDT. BlackRock Inc. purchased a new stake in shares of Ardent Health during the second quarter valued at $21,415,000. First Trust Advisors LP increased its holdings in Ardent Health by 5.9% in the 3rd quarter. First Trust Advisors LP now owns 595,710 shares of the company’s stock worth $6,160,000 after buying an additional 33,432 shares in the last quarter. Algert Global LLC increased its holdings in Ardent Health by 1,277.3% in the 2nd quarter. Algert Global LLC now owns 597,745 shares of the company’s stock worth $5,882,000 after buying an additional 554,345 shares in the last quarter. Empowered Funds LLC increased its holdings in Ardent Health by 1.0% in the 3rd quarter. Empowered Funds LLC now owns 556,586 shares of the company’s stock worth $5,755,000 after buying an additional 5,293 shares in the last quarter. Finally, Goldman Sachs Group Inc. raised its position in Ardent Health by 51.2% in the 3rd quarter. Goldman Sachs Group Inc. now owns 460,317 shares of the company’s stock worth $4,760,000 after buying an additional 155,868 shares during the last quarter.
Ardent Health Company Profile
Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.
Further Reading
- Five stocks we like better than Ardent Health
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
